Page 1 | Search Results | Clinical Science

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Articles

β-Pro 7 Ang III is a novel highly selective angiotensin II type 2 receptor (AT 2 R) agonist, which acts as a vasodepressor agent via the AT 2 R in conscious spontaneously hypertensive rats

Mark Del Borgo, Yan Wang, Sanja Bosnyak, Morimer Khan, Pia Walters, Iresha Spizzo, Patrick Perlmutter, Lucinda Hilliard, Kate Denton, Marie-Isabel Aguilar, Robert E. Widdop, Emma S. Jones

Clin Sci (Lond) (2015) 129 (6): 505–513.

https://doi.org/10.1042/CS20150077

Published: 22 June 2015

View article titled, β-Pro 7 Ang III is a novel highly selective angiotensin II type 2 receptor (AT 2 R) agonist, which acts as a vasodepressor agent via the AT 2 R in conscious spontaneously hypertensive rats

Portland Press

Registered address – First Floor, 10 Queen Street Place, London EC4R 1BE
Mailing address – 1 Naoroji Street, London WC1X 0GB

Portland Press Tel
+44 (0)20 3880 2795
Portland Press Company no. 02453983

Biochemical Society Tel
+44 (0)20 3880 2793
Email: [email protected]

Biochemical Society Company no. 00892796
Registered Charity no. 253894
VAT no. GB 523 2392 69

Privacy and cookies
Accessibility

NARROW

β-Pro 7 Ang III is a novel highly selective angiotensin II type 2 receptor (AT 2 R) agonist, which acts as a vasodepressor agent via the AT 2 R in conscious spontaneously hypertensive rats

Email alerts

CONNECT

EXPLORE

β-Pro 7 Ang III is a novel highly selective angiotensin II type 2 receptor (AT 2 R) agonist, which acts as a vasodepressor agent via the AT 2 R in conscious spontaneously hypertensive rats

Email alerts

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only